Local: (502) 749-5700
Cell: (502) 649-1234 Home: (502) 228-5112
Since 1991, Brett Oppenheimer has had the honor of fighting for victims and families who have suffered serious losses due to the negligence of others. Brett Oppenheimer has a wealth of experience in cases involving personal injury, Auto Accidents, nursing home abuse, medical malpractice, defective drugs, product liability, and more. In addition to years of work in Kentucky, being born and raised in Louisville has given Brett Oppenheimer a unique ability to understand and best protect the interests of his clients.
Brett will talk with you as many times as necessary, without charge, until we determine if my team and I will be able to help.
Absolutely no fee unless and until my team and I successfully settle or win your case. If we are unsuccessful, I will not charge you and you will not be responsible for costs or expenses (unless otherwise agreed).
Attorney Brett H. Oppenheimer explains the purpose of the phone call blog. He believes it is an opportunity to share some of the stories and inquiries that come to him by email and telephone so you can learn about the types of cases he and his staff consider. The phone call blog is a compilation of stories that come to him from people just like you. To learn more about the phone call blog, please view this short video.
A man in his twenties contacted our office to discuss a significant injury he suffered while using a table saw. Every year, tens of thousands of injuries are suffered by table saw users. Many injuries occur as a result of kick-back, and that is exactly what happened to this man. Kick-back can... read more
A woman in her mid-fifties contacted our office to discuss her recent diagnosis of Type II Diabetes. She had been prescribed Lipitor to help lower her cholesterol. In fact, results from a recent study showed a drastic increase in Type II Diabetes in menopausal women using Lipitor. One of the criteria as... read more
We were contacted by a middle aged woman who had recently undergone surgery. She and her family were told that her surgery was anticipated to last approximately an hour and a half. Concerns arose during the surgery and, ultimately, the surgery lasted almost six hours. When the patient awoke, she had pain,... read more
We were contacted by the father of a young man who had developed large breasts over the past year or so. This teenager was taking a medication called Risperdal (made by Johnson & Johnson) and had developed a condition called Gynecomastia. He developed breasts that would be typical of a post-puberty female.... read more
Even though it is less common for a male patient to undergo an ERCP (Endoscopic Retrograde Cholangiopancreatography) than a female patient, sometimes men do undergo this test. This caller was a middle aged male who had undergone an ERCP and had suffered the complications known as pancreatitis. ERCP is a method for... read more
A call was received from a spine fusion surgery patient who had seen our marketing materials about cases involving Medtronic Infuse®. The caller was advised that early evaluation of potential Infuse® cases require a review of the operative report to confirm that the surgeon used Medtronic Infuse® and to confirm how the... read more
February 26, 2014 | By Tracy Staton Once again, the U.S. government has tallied up its health-fraud haul, and once again, its prosecutions set a record. And as usual, the pharma business accounted for the lion's share of the total. The departments of Justice and Health and Human Services recouped $4.3 billion in criminal... read more
Bloomberg News (2/25, Feeley, Cortez, 1.91M) reported Boehringer Ingelheim GmbH failed to reveal "a data analysis to U.S. regulators that" suggested the blood-thinner Pradaxa "may have caused more fatal bleeding after it was cleared for sale than the drug did in a study used to win approval," citing unsealed court filings. Boehringer... read more
By Katie Thomas Feb. 5, 2014 The makers of the blood-thinning drug Pradaxa were so worried that an internal research paper would damage drug sales that some employees not only pressured the author to revise it, but suggested it should be quashed altogether, according to newly unsealed legal documents. The documents were made public... read more
February 12, 2014 | By Mark Hollmer A Teleflex ($TFX) subsidiary is voluntarily recalling one of its tracheal tubes because of reports that it can kink during use and cut off a patient's air supply. The FDA slapped its Class I recall designation on the Pennsylvania company's action, meaning the defect carries with... read more
The 5 men claim they had either a heart attack or a stroke after starting on AndroGel February 6, 2014 | By Eric Palmer The FDA said last week it was going to investigate the heart and stroke dangers that recent studies suggest are tied to use of testosterone-enhancing drugs. Five days later, 5... read more